Melatonin role preventing steatohepatitis and improving liver transplantation results

Eduardo Esteban-Zubero, Francisco Agustín García-Gil, Laura López-Pingarrón, Moisés Alejandro Alatorre-Jiménez, José Manuel Ramírez, Dun Xian Tan, José Joaquín García, Russel J Reiter

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Liver steatosis is a prevalent process that is induced due to alcoholic or non-alcoholic intake. During the course of these diseases, the generation of reactive oxygen species, followed by molecular damage to lipids, protein and DMA occurs generating organ cell death. Transplantation is the last-resort treatment for the end stage of both acute and chronic hepatic diseases, but its success depends on ability to control ischemia–reperfusion injury, preservation fluids used, and graft quality. Melatonin is a powerful endogenous antioxidant produced by the pineal gland and a variety of other because of its efficacy in organs; melatonin has been investigated to improve the outcome of organ transplantation by reducing ischemia–reperfusion injury and due to its synergic effect with organ preservation fluids. Moreover, this indolamine also prevent liver steatosis. That is important because this disease may evolve leading to an organ transplantation. This review summarizes the observations related to melatonin beneficial actions in organ transplantation and ischemic–reperfusion models.

Original languageEnglish (US)
Pages (from-to)1-17
Number of pages17
JournalCellular and Molecular Life Sciences
DOIs
StateAccepted/In press - Mar 29 2016

Fingerprint

Organ Transplantation
Melatonin
Fatty Liver
Liver Transplantation
Organ Preservation
Pineal Gland
Wounds and Injuries
Reactive Oxygen Species
Chronic Disease
Cell Death
Antioxidants
Transplantation
Transplants
Lipids
Liver
Proteins
Therapeutics

Keywords

  • Alcohol
  • Ischemia–reperfusion injury
  • Liver transplantation
  • Melatonin
  • Preservation fluids
  • Steatosis

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Molecular Medicine
  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Esteban-Zubero, E., García-Gil, F. A., López-Pingarrón, L., Alatorre-Jiménez, M. A., Ramírez, J. M., Tan, D. X., ... Reiter, R. J. (Accepted/In press). Melatonin role preventing steatohepatitis and improving liver transplantation results. Cellular and Molecular Life Sciences, 1-17. https://doi.org/10.1007/s00018-016-2185-2

Melatonin role preventing steatohepatitis and improving liver transplantation results. / Esteban-Zubero, Eduardo; García-Gil, Francisco Agustín; López-Pingarrón, Laura; Alatorre-Jiménez, Moisés Alejandro; Ramírez, José Manuel; Tan, Dun Xian; García, José Joaquín; Reiter, Russel J.

In: Cellular and Molecular Life Sciences, 29.03.2016, p. 1-17.

Research output: Contribution to journalArticle

Esteban-Zubero, E, García-Gil, FA, López-Pingarrón, L, Alatorre-Jiménez, MA, Ramírez, JM, Tan, DX, García, JJ & Reiter, RJ 2016, 'Melatonin role preventing steatohepatitis and improving liver transplantation results', Cellular and Molecular Life Sciences, pp. 1-17. https://doi.org/10.1007/s00018-016-2185-2
Esteban-Zubero E, García-Gil FA, López-Pingarrón L, Alatorre-Jiménez MA, Ramírez JM, Tan DX et al. Melatonin role preventing steatohepatitis and improving liver transplantation results. Cellular and Molecular Life Sciences. 2016 Mar 29;1-17. https://doi.org/10.1007/s00018-016-2185-2
Esteban-Zubero, Eduardo ; García-Gil, Francisco Agustín ; López-Pingarrón, Laura ; Alatorre-Jiménez, Moisés Alejandro ; Ramírez, José Manuel ; Tan, Dun Xian ; García, José Joaquín ; Reiter, Russel J. / Melatonin role preventing steatohepatitis and improving liver transplantation results. In: Cellular and Molecular Life Sciences. 2016 ; pp. 1-17.
@article{dba6ba40de3947009a4c4f07eae7a4ae,
title = "Melatonin role preventing steatohepatitis and improving liver transplantation results",
abstract = "Liver steatosis is a prevalent process that is induced due to alcoholic or non-alcoholic intake. During the course of these diseases, the generation of reactive oxygen species, followed by molecular damage to lipids, protein and DMA occurs generating organ cell death. Transplantation is the last-resort treatment for the end stage of both acute and chronic hepatic diseases, but its success depends on ability to control ischemia–reperfusion injury, preservation fluids used, and graft quality. Melatonin is a powerful endogenous antioxidant produced by the pineal gland and a variety of other because of its efficacy in organs; melatonin has been investigated to improve the outcome of organ transplantation by reducing ischemia–reperfusion injury and due to its synergic effect with organ preservation fluids. Moreover, this indolamine also prevent liver steatosis. That is important because this disease may evolve leading to an organ transplantation. This review summarizes the observations related to melatonin beneficial actions in organ transplantation and ischemic–reperfusion models.",
keywords = "Alcohol, Ischemia–reperfusion injury, Liver transplantation, Melatonin, Preservation fluids, Steatosis",
author = "Eduardo Esteban-Zubero and Garc{\'i}a-Gil, {Francisco Agust{\'i}n} and Laura L{\'o}pez-Pingarr{\'o}n and Alatorre-Jim{\'e}nez, {Mois{\'e}s Alejandro} and Ram{\'i}rez, {Jos{\'e} Manuel} and Tan, {Dun Xian} and Garc{\'i}a, {Jos{\'e} Joaqu{\'i}n} and Reiter, {Russel J}",
year = "2016",
month = "3",
day = "29",
doi = "10.1007/s00018-016-2185-2",
language = "English (US)",
pages = "1--17",
journal = "Cellular and Molecular Life Sciences",
issn = "1420-682X",
publisher = "Birkhauser Verlag Basel",

}

TY - JOUR

T1 - Melatonin role preventing steatohepatitis and improving liver transplantation results

AU - Esteban-Zubero, Eduardo

AU - García-Gil, Francisco Agustín

AU - López-Pingarrón, Laura

AU - Alatorre-Jiménez, Moisés Alejandro

AU - Ramírez, José Manuel

AU - Tan, Dun Xian

AU - García, José Joaquín

AU - Reiter, Russel J

PY - 2016/3/29

Y1 - 2016/3/29

N2 - Liver steatosis is a prevalent process that is induced due to alcoholic or non-alcoholic intake. During the course of these diseases, the generation of reactive oxygen species, followed by molecular damage to lipids, protein and DMA occurs generating organ cell death. Transplantation is the last-resort treatment for the end stage of both acute and chronic hepatic diseases, but its success depends on ability to control ischemia–reperfusion injury, preservation fluids used, and graft quality. Melatonin is a powerful endogenous antioxidant produced by the pineal gland and a variety of other because of its efficacy in organs; melatonin has been investigated to improve the outcome of organ transplantation by reducing ischemia–reperfusion injury and due to its synergic effect with organ preservation fluids. Moreover, this indolamine also prevent liver steatosis. That is important because this disease may evolve leading to an organ transplantation. This review summarizes the observations related to melatonin beneficial actions in organ transplantation and ischemic–reperfusion models.

AB - Liver steatosis is a prevalent process that is induced due to alcoholic or non-alcoholic intake. During the course of these diseases, the generation of reactive oxygen species, followed by molecular damage to lipids, protein and DMA occurs generating organ cell death. Transplantation is the last-resort treatment for the end stage of both acute and chronic hepatic diseases, but its success depends on ability to control ischemia–reperfusion injury, preservation fluids used, and graft quality. Melatonin is a powerful endogenous antioxidant produced by the pineal gland and a variety of other because of its efficacy in organs; melatonin has been investigated to improve the outcome of organ transplantation by reducing ischemia–reperfusion injury and due to its synergic effect with organ preservation fluids. Moreover, this indolamine also prevent liver steatosis. That is important because this disease may evolve leading to an organ transplantation. This review summarizes the observations related to melatonin beneficial actions in organ transplantation and ischemic–reperfusion models.

KW - Alcohol

KW - Ischemia–reperfusion injury

KW - Liver transplantation

KW - Melatonin

KW - Preservation fluids

KW - Steatosis

UR - http://www.scopus.com/inward/record.url?scp=84962298587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962298587&partnerID=8YFLogxK

U2 - 10.1007/s00018-016-2185-2

DO - 10.1007/s00018-016-2185-2

M3 - Article

C2 - 27022943

AN - SCOPUS:84962298587

SP - 1

EP - 17

JO - Cellular and Molecular Life Sciences

JF - Cellular and Molecular Life Sciences

SN - 1420-682X

ER -